← Human Trials & Peer-Reviewed Studies
Comparison of self-reported and monitored compliance of daily injection of human growth hormone in burned children.
Plain-language guide to PMID 14556728 (2003): double-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 14556728
- Journal
- Burns : journal of the International Society for Burn Injuries
- Year
- 2003
- Study type
- Randomized Controlled Trial
- Authors
- Wilkins JP et al. (4 authors)
- DOI
- 10.1016/s0305-4179(03)00158-x
What This Study Did, in Plain Language
What Was Tested
Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.
The researchers compared insulin-like growth factor (IGF-I) levels obtained in two groups with different methods of assessing compliance.
A self-reported group completed a Self Reported Compliance Questionnaire (SRCQ) that assessed compliance with drug regimen.
Who Took Part
PubMed indexes the participants as infants, young children, children and teenagers, both men and women.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.
As a double-blind Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.
What Was Measured
The researchers compared insulin-like growth factor (IGF-I) levels obtained in two groups with different methods of assessing compliance.
A self-reported group completed a Self Reported Compliance Questionnaire (SRCQ) that assessed compliance with drug regimen.
The subject headings attached to it are Analysis of Variance, Burns, Drug Monitoring, Human Growth Hormone, Insulin-Like Growth Factor I, Patient Compliance and Recombinant Proteins.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The publication is from 2003 (Burns : journal of the International Society for Burn Injuries), a journal based in Netherlands.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.